Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Muscular dystrophies with reduced glycosylation of alpha-dystroglycan (alpha-DG), commonly referred to as dystroglycanopathies, are a heterogeneous group of autosomal recessive conditions which include a wide spectrum of clinical severity. Reported phenotypes range from severe congenital onset Walker-Warburg syndrome (WWS) with severe structural brain and eye involvement, to relatively mild adult onset limb girdle muscular dystrophy (LGMD). Specific clinical syndromes were originally described in association with mutations in any one of six demonstrated or putative glycosyltransferases. Work performed on patients with mutations in the FKRP gene has identified that the spectrum of phenotypes due to mutations in this gene is much wider than originally assumed. To further define the mutation frequency and phenotypes associated with mutations in the other five genes, we studied a large cohort of patients with evidence of a dystroglycanopathy. Exclusion of mutations in FKRP was a prerequisite for participation in this study. Ninety-two probands were screened for mutations in POMT1, POMT2, POMGnT1, fukutin and LARGE. Homozygous and compound heterozygous mutations were detected in a total of 31 probands (34 individuals from 31 families); 37 different mutations were identified, of which 32 were novel. Mutations in POMT2 were the most prevalent in our cohort with nine cases, followed by POMT1 with eight cases, POMGnT1 with seven cases, fukutin with six cases and LARGE with only a single case. All patients with POMT1 and POMT2 mutations had evidence of either structural or functional central nervous system involvement including four patients with mental retardation and a LGMD phenotype. In contrast mutations in fukutin and POMGnT1 were detected in four patients with LGMD and no evidence of brain involvement. The majority of patients (six out of nine) with mutations in POMT2 had a Muscle-Eye-Brain (MEB)-like condition. In addition we identified a mutation in the gene LARGE in a patient with WWS. Our data expands the clinical phenotypes associated with POMT1, POMT2, POMGnT1, fukutin and LARGE mutations. Mutations in these five glycosyltransferase genes were detected in 34% of patients indicating that, after the exclusion of FKRP, the majority of patients with a dystroglycanopathy harbour mutations in novel genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A child affected with ASD and moderate intellectual disability was found to have a homozygous missense change (p.R367H) in POMGNT1 (Table 1B; Figure S4). POMGNT1 is responsible for an inherited dystroglycanopathy characterized by brain malformation, intellectual disability, developmental delay, hypotonia, and myopia; interestingly, rare patients have been reported with severe autistic features (”
From Using Whole-Exome Sequencing to Identify Inherited Causes of Autism (2013) · cites this paper as Godfrey et al., 2007
Citations
Cites
Muscle Biopsy: A Practical Approach
Dubowitz, V., Sewry, C. A., Oldfors, A., & Lane, R. J. M. (2020) · Cited by 1,335
Self-citationAn ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
Kobayashi, K., Nakahori, Y., Miyake, M., Matsumura, K., Kondo-Iida, E., Nomura, Y., Segawa, M., Yoshioka, M., Saito, K., Osawa, M., et al. (1998) · Nature · doi:10.1038/28653 · Cited by 802
Yoshida, A., Kobayashi, K., Manya, H., Taniguchi, K., Kano, H., Mizuno, M., Inazu, T., Mitsuhashi, H., Takahashi, S., Takeuchi, M., et al. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00070-3 · Cited by 706 · cited 2×
“These genes are thought to be involved in the addition of carbohydrate residues onto the -DG backbone either via the process of O-mannosylation (POMT1, POMT2, POMGnT1) (Yoshida et al., 2001; Manya et al., 2003; Akasaka-Manya et al., 2004) or via other not fully characterized mechanisms (fukutin, FKRP and LARGE) (de Pa…”
BackgroundSelf-citationBeltrán-Valero de Bernabé, D., Currier, S., Steinbrecher, A., Celli, J., van Beusekom, E., van der Zwaag, B., Kayserili, H., Merlini, L., Chitayat, D., Dobyns, W. B., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342975 · Cited by 685
Brockington, M., Blake, D. J., Prandini, P., Brown, S. C., Torelli, S., Benson, M. A., Ponting, C. P., Estournet, B., Romero, N. B., Mercuri, E., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/324412 · Cited by 603
Self-citationDystroglycan: from biosynthesis to pathogenesis of human disease
Barresi, R., & Campbell, K. P. (2006) · Journal of Cell Science · doi:10.1242/jcs.02814 · Cited by 596
Williamson, R. A., Henry, M. D., Daniels, K. J., Hrstka, R. F., Lee, J. C., Sunada, Y., Ibraghimov-Beskrovnaya, O., & Campbell, K. P. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.6.831 · Cited by 541
Brockington, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2851 · Cited by 499
Self-citationLongman, C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg307 · Cited by 416
Self-citationPOMT2 mutations cause α-dystroglycan hypoglycosylation and Walker-Warburg syndrome
van Reeuwijk, J., Janssen, M., van den Elzen, C., Beltran-Valero de Bernabé, D., Sabatelli, P., Merlini, L., Boon, M., Scheffer, H., Brockington, M., Muntoni, F., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.031963 · Cited by 414
Self-citation
Cited by
Prevalence of Muscular Dystrophies: A Systematic Literature Review
Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., Jones, K., Krishnamurthi, R., & Feigin, V. (2014) · Neuroepidemiology · doi:10.1159/000369343 · Cited by 2,046
A developmental and genetic classification for malformations of cortical development: update 2012
Barkovich, A. J., Guerrini, R., Kuzniecky, R. I., Jackson, G. D., & Dobyns, W. B. (2012) · Brain · doi:10.1093/brain/aws019 · Cited by 1,104
Mercuri, E., Bönnemann, C. G., & Muntoni, F. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32910-1 · Cited by 551
Self-citationUsing Whole-Exome Sequencing to Identify Inherited Causes of Autism
Yu, T. W., Chahrour, M. H., Coulter, M. E., Jiralerspong, S., Okamura-Ikeda, K., Ataman, B., Schmitz-Abe, K., Harmin, D. A., Adli, M., Malik, A. N., et al. (2013) · Neuron · doi:10.1016/j.neuron.2012.11.002 · Cited by 442
“The p.R367H missense variant in this patient disrupts a highly conserved residue, and this exact allele has been reported as causative in a patient with relatively mild clinical disease, as a compound heterozygousmutation in combination with a splice site mutation (Godfrey et al., 2007).”
BackgroundMercuri, E., & Muntoni, F. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61897-2 · Cited by 434
Self-citationDiagnostic approach to the congenital muscular dystrophies
Bönnemann, C. G., Wang, C. H., Quijano-Roy, S., Deconinck, N., Bertini, E., Ferreiro, A., Muntoni, F., Sewry, C., Béroud, C., Mathews, K. D., et al. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.12.011 · Cited by 340
Self-citationA new face and new challenges for Online Mendelian Inheritance in Man (OMIM®)
Amberger, J., Bocchini, C., & Hamosh, A. (2011) · Human Mutation · doi:10.1002/humu.21466 · Cited by 332
Genetic basis of limb-girdle muscular dystrophies: the 2014 update.
Nigro, V., & Savarese, M. (2014) · PubMed Central · Cited by 310
A developmental and genetic classification for midbrain-hindbrain malformations
Barkovich, A. J., Millen, K. J., & Dobyns, W. B. (2009) · Brain · doi:10.1093/brain/awp247 · Cited by 285
A Dystroglycan Mutation Associated with Limb-Girdle Muscular Dystrophy
Hara, Y., Balci-Hayta, B., Yoshida-Moriguchi, T., Kanagawa, M., Beltrán-Valero de Bernabé, D., Gündeşli, H., Willer, T., Satz, J. S., Crawford, R. W., Burden, S. J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1006939 · Cited by 283
Self-citationOtto, A., Schmidt, C., Luke, G., Allen, S., Valasek, P., Muntoni, F., Lawrence-Watt, D., & Patel, K. (2008) · Journal of Cell Science · doi:10.1242/jcs.026534 · Cited by 280
Self-citationDystroglycanopathies: coming into focus
Godfrey, C., Foley, A. R., Clement, E., & Muntoni, F. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.02.001 · Cited by 248
Self-citationProtein O-mannosylation: Conserved from bacteria to humans
Lommel, M., & Strahl, S. (2009) · Glycobiology · doi:10.1093/glycob/cwp066 · Cited by 242
Willer, T., Lee, H., Lommel, M., Yoshida-Moriguchi, T., de Bernabe, D. B. V., Venzke, D., Cirak, S., Schachter, H., Vajsar, J., Voit, T., et al. (2012) · Nature Genetics · doi:10.1038/ng.2252 · Cited by 238
Self-citationCarss, K. J., Stevens, E., Foley, A. R., Cirak, S., Riemersma, M., Torelli, S., Hoischen, A., Willer, T., van Scherpenzeel, M., Moore, S. A., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.05.009 · Cited by 233
Self-citationNarayanaswami, P., Weiss, M., Selcen, D., David, W., Raynor, E., Carter, G., Wicklund, M., Barohn, R. J., Ensrud, E., Griggs, R. C., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000892 · Cited by 232
Consensus Statement on Standard of Care for Congenital Muscular Dystrophies
Wang, C. H., Bonnemann, C. G., Rutkowski, A., Sejersen, T., Bellini, J., Battista, V., Florence, J. M., Schara, U., Schuler, P. M., Wahbi, K., et al. (2010) · Journal of Child Neurology · doi:10.1177/0883073810381924 · Cited by 219
Self-citationThe dystrophin–glycoprotein complex in brain development and disease
Waite, A., Brown, S. C., & Blake, D. J. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.04.004 · Cited by 215
Self-citationMutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan
Roscioli, T., Kamsteeg, E.-J., Buysse, K., Maystadt, I., van Reeuwijk, J., van den Elzen, C., van Beusekom, E., Riemersma, M., Pfundt, R., Vissers, L. E. L. M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2253 · Cited by 211
Lefeber, D. J., Schönberger, J., Morava, E., Guillard, M., Huyben, K. M., Verrijp, K., Grafakou, O., Evangeliou, A., Preijers, F. W., Manta, P., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.06.006 · Cited by 196
Congenital Abnormalities of the Posterior Fossa
Bosemani, T., Orman, G., Boltshauser, E., Tekes, A., Huisman, T. A. G. M., & Poretti, A. (2015) · RadioGraphics · doi:10.1148/rg.351140038 · Cited by 192
Mutations in B3GALNT2 Cause Congenital Muscular Dystrophy and Hypoglycosylation of α-Dystroglycan
Stevens, E., Carss, K. J., Cirak, S., Foley, A. R., Torelli, S., Willer, T., Tambunan, D. E., Yau, S., Brodd, L., Sewry, C. A., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.01.016 · Cited by 192
Self-citationDevisme, L., Bouchet, C., Gonzalès, M., Alanio, E., Bazin, A., Bessières, B., Bigi, N., Blanchet, P., Bonneau, D., Bonnières, M., et al. (2012) · Brain · doi:10.1093/brain/awr357 · Cited by 192
Congenital muscular dystrophies with defective glycosylation of dystroglycan: A population study
Mercuri, E., Messina, S., Bruno, C., Mora, M., Pegoraro, E., Comi, G. P., D'Amico, A., Aiello, C., Biancheri, R., Berardinelli, A., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000346518.68110.60 · Cited by 192
Self-citationHaeuptle, M. A., & Hennet, T. (2009) · Human Mutation · doi:10.1002/humu.21126 · Cited by 185
Brain involvement in muscular dystrophies with defective dystroglycan glycosylation
Clement, E., Mercuri, E., Godfrey, C., Smith, J., Robb, S., Kinali, M., Straub, V., Bushby, K., Manzur, A., Talim, B., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21482 · Cited by 181
Self-citationCalpain 3, the “gatekeeper” of proper sarcomere assembly, turnover and maintenance
Beckmann, J. S., & Spencer, M. J. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.08.005 · Cited by 178
The Diverse Genetic Landscape of Neurodevelopmental Disorders
Hu, W. F., Chahrour, M. H., & Walsh, C. A. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025600 · Cited by 172
Glycobiology of -dystroglycan and muscular dystrophy
Endo, T. (2015) · Journal of Biochemistry · doi:10.1093/jb/mvu066 · Cited by 156
Distinct Functions of Glial and Neuronal Dystroglycan in the Developing and Adult Mouse Brain
Satz, J. S., Ostendorf, A. P., Hou, S., Turner, A., Kusano, H., Lee, J. C., Turk, R., Nguyen, H., Ross-Barta, S. E., Westra, S., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3247-10.2010 · Cited by 158
Identification of Mutations in TMEM5 and ISPD as a Cause of Severe Cobblestone Lissencephaly
Vuillaumier‐Barrot, S., Bouchet-Séraphin, C., Chelbi, M., Devisme, L., Quentin, S., Gazal, S., Laquerrière, A., Fallet‐Bianco, C., Loget, P., Odent, S., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.10.009 · Cited by 153
The neurobiology of the dystrophin-associated glycoprotein complex
Waite, A. J., Tinsley, C. L., Locke, M., & Blake, D. J. (2009) · Annals of Medicine · doi:10.1080/07853890802668522 · Cited by 153
The role of pericytic laminin in blood brain barrier integrity maintenance
Gautam, J., Zhang, X., & Yao, Y. (2016) · Scientific Reports · doi:10.1038/srep36450 · Cited by 138
Midbrain and hindbrain malformations: advances in clinical diagnosis, imaging, and genetics
Doherty, D., Millen, K. J., & Barkovich, A. J. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70024-3 · Cited by 146
Bahi-Buisson, N., Poirier, K., Boddaert, N., Fallet-Bianco, C., Specchio, N., Bertini, E., Caglayan, O., Lascelles, K., Elie, C., Rambaud, J., et al. (2010) · Brain · doi:10.1093/brain/awq259 · Cited by 144
Limb–girdle muscular dystrophies
Guglieri, M., Straub, V. W., Bushby, K., & Lochmüller, H. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32830efdc2 · Cited by 137
Self-citationJimenez-Mallebrera, C., Torelli, S., Feng, L., Kim, J., Godfrey, C., Clement, E. M., Mein, R., Abbs, S. J., Brown, S., Campbell, K. P., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00198.x · Cited by 135
Self-citationThe Genetic Basis of Hydrocephalus
Kousi, M., & Katsanis, N. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-014023 · Cited by 135
The ever‐expanding spectrum of congenital muscular dystrophies
Mercuri, E. M., & Muntoni, F. (2012) · Annals of Neurology · doi:10.1002/ana.23548 · Cited by 133
Self-citationMuscular Dystrophies Due to Glycosylation Defects
Muntoni, F., Torelli, S., & Brockington, M. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.08.005 · Cited by 133
Self-citationSframeli, M., Sárközy, A., Bértoli, M., Astrea, G., Hudson, J. A., Scoto, M., Mein, R., Yau, M., Phadke, R., Feng, L., et al. (2017) · Neuromuscular Disorders · doi:10.1016/j.nmd.2017.06.008 · Cited by 132
Self-citationMuscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies
Muntoni, F., Torelli, S., Wells, D. J., & Brown, S. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834a95e3 · Cited by 127
Self-citationCongenital Muscular Dystrophies: A Brief Review
Bertini, E., D’Amico, A., Gualandi, F., & Petrini, S. (2011) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2011.10.010 · Cited by 126
Diagnosis and management of the limb girdle muscular dystrophies
Bushby, K. M. D. (2009) · Practical Neurology · doi:10.1136/jnnp.2009.193938 · Cited by 121
Self-citationKang, P. B., Morrison, L., Iannaccone, S., Graham, R., Bonnemann, C., Rutkowski, A., Hornyak, J., Wang, C. H., North, K., Oskoui, M., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001416 · Cited by 71
Self-citationCell–matrix interactions in muscle disease
Carmignac, V., & Durbeej, M. (2011) · The Journal of Pathology · doi:10.1002/path.3020 · Cited by 113
Dai, Y., Liang, S., Dong, X., Zhao, Y., Ren, H., Guan, Y., Yin, H., Li, C., Chen, L., Cui, L., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13979 · Cited by 113
Diagnosis and etiology of congenital muscular dystrophy
Peat, R. A., Smith, J. M., Compton, A. G., Baker, N. L., Pace, R. A., Burkin, D. J., Kaufman, S. J., Lamandé, S. R., & North, K. N. (2007) · Neurology · doi:10.1212/01.wnl.0000284605.27654.5a · Cited by 110
Self-citationPrevalence of congenital muscular dystrophy in Italy: A population study
Graziano, A., Bianco, F., D’Amico, A., Moroni, I., Messina, S., Bruno, C., Pegoraro, E., Mora, M., Astrea, G., Magri, F., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001303 · Cited by 108
Self-citationISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies
Çırak, S., Foley, A. R., Herrmann, R., Willer, T., Yau, S., Stevens, E., Torelli, S., Brodd, L., Kamynina, A., Vondráček, P., et al. (2013) · Brain · doi:10.1093/brain/aws312 · Cited by 107
Self-citationMyshrall, T. D., Moore, S. A., Ostendorf, A. P., Satz, J. S., Kowalczyk, T., Nguyen, H., Daza, R. A. M., Lau, C., Campbell, K. P., & Hevner, R. F. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318274a128 · Cited by 106
Congenital muscular dystrophy: from muscle to brain
Falsaperla, R., Praticò, A. D., Ruggieri, M., Parano, E., Rizzo, R., Corsello, G., Vitaliti, G., & Pavone, P. (2016) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-016-0289-9 · Cited by 103
Satz, J. S., Barresi, R., Durbeej, M., Willer, T., Turner, A., Moore, S. A., & Campbell, K. P. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2457-08.2008 · Cited by 101
Wells, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.438978 · Cited by 84
Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects
Reed, U. C. (2009) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2009000100038 · Cited by 94
Insight into the molecular genetics of myopia.
Li, J., & Zhang, Q. (2017) · PubMed Central · Cited by 93
The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy
Nickolls, A. R., & Bönnemann, C. G. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035931 · Cited by 93
Nilsson, J., Nilsson, J., Larson, G., & Grahn, A. (2010) · Glycobiology · doi:10.1093/glycob/cwq082 · Cited by 91
Mammalian O-Mannosylation Pathway: Glycan Structures, Enzymes, and Protein Substrates
Praissman, J. L., & Wells, L. (2014) · Biochemistry · doi:10.1021/bi500153y · Cited by 91
Taniguchi‐Ikeda, M., Morioka, I., Iijima, K., & Toda, T. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.07.003 · Cited by 91
Flanigan, K. M. (2012) · Seminars in Neurology · doi:10.1055/s-0032-1329199 · Cited by 90
Früh, S., Romanos, J., Panzanelli, P., Bürgisser, D., Tyagarajan, S. K., Campbell, K. P., Santello, M., & Fritschy, J.-M. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1823-16.2016 · Cited by 87
Kanagawa, M., Nishimoto, A., Chiyonobu, T., Takeda, S., Miyagoe‐Suzuki, Y., Wang, F., Fujikake, N., Taniguchi, M., Lu, Z., Tachikawa, M., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn387 · Cited by 89
POMK mutations disrupt muscle development leading to a spectrum of neuromuscular presentations
Costanzo, S. D., Balasubramanian, A., Pond, H. L., Rozkalne, A., Pantaleoni, C., Saredi, S., Gupta, V., Sunu, C., Yu, T. W., Kang, P. B., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu296 · Cited by 88
Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies
Lin, Y., White, R. J., Torelli, S., Çırak, S., Muntoni, F., & Stemple, D. L. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr059 · Cited by 86
Self-citationAbnormal glycosylation of dystroglycan in human genetic disease
Hewitt, J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.003 · Cited by 85
Therapeutic advances in muscular dystrophy
Leung, D. G., & Wagner, K. R. (2013) · Annals of Neurology · doi:10.1002/ana.23989 · Cited by 84
Geis, T., Marquard, K., Rödl, T., Reihle, C., Schirmer, S., Kalle, T. V., Bornemann, A., Hehr, U., & Blankenburg, M. R. (2013) · Neurogenetics · doi:10.1007/s10048-013-0374-9 · Cited by 83
Manzini, M. C., Gleason, D., Chang, B. S., Hill, R. S., Barry, B. J., Partlow, J. N., Poduri, A., Currier, S., Galvin‐Parton, P., Shapiro, L. R., et al. (2008) · Human Mutation · doi:10.1002/humu.20844 · Cited by 76
Clement, E. M., Feng, L., Mein, R., Sewry, C. A., Robb, S. A., Manzur, A. Y., Mercuri, E. M., Godfrey, C., Cullup, T., Abbs, S. J., et al. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.01.010 · Cited by 75
Self-citationUpdate on the Genetics of Limb Girdle Muscular Dystrophy
Mitsuhashi, S., & Kang, P. B. (2012) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2012.09.008 · Cited by 75
Ackroyd, M. R., Skordis, L., Kaluarachchi, M. R., Godwin, J., Prior, S., Fidanboylu, M., Piercy, R. J., Muntoni, F., & Brown, S. (2008) · Brain · doi:10.1093/brain/awn335 · Cited by 74
Self-citationDiagnosis and etiology of congenital muscular dystrophy: We are halfway there
O’Grady, G. L., Lek, M., Lamandé, S. R., Waddell, L. B., Oates, E. C., Punetha, J., Ghaoui, R., Sandaradura, S. A., Best, H. A., Kaur, S., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24687 · Cited by 74
Self-citationThe genetics of cerebellar malformations
Aldinger, K. A., & Doherty, D. (2016) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2016.04.008 · Cited by 71
Limb-girdle muscular dystrophies: Where next after six decades from the first proposal (Review)
Mahmood, O. A., & Jiang, X. M. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2048 · Cited by 70
Qiao, C., Wang, C., Zhao, C., Lu, P., Awano, H., Xiao, B., Li, J., Yuan, Z., Dai, Y., Martin, C. B., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.141 · Cited by 69
A glycogene mutation map for discovery of diseases of glycosylation
Hansen, L. H., Lind-Thomsen, A., Joshi, H. J., Borbye‐Lorenzen, N., Have, C. T., Kong, Y., Wang, S., Sparsø, T., Grarup, N., Vester-Christensen, M. B., et al. (2014) · Glycobiology · doi:10.1093/glycob/cwu104 · Cited by 69
Muscular dystrophies due to defective glycosylation of dystroglycan.
Muntoni, F., Brockington, M., Godfrey, C., Ackroyd, M. R., Robb, S. A., Manzur, A. Y., Kinali, M., Mercuri, E. M., Kaluarachchi, M. R., Feng, L., et al. (2007) · Europe PMC (PubMed Central) · Cited by 69
Self-citationSynaptic Defects in aDrosophilaModel of Congenital Muscular Dystrophy
Wairkar, Y. P., Fradkin, L. G., Noordermeer, J. N., & DiAntonio, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0478-08.2008 · Cited by 68
Gatheridge, M. A., Kwon, J. M., Mendell, J., Scheuerbrandt, G., Moat, S. J., Eyskens, F. J. M., Greenberg, C. R., Drousiotou, A., & Griggs, R. C. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.3537 · Cited by 68
Pirolli, D., Sciandra, F., Bozzi, M., Giardina, B., Brancaccio, A., & Rosa, M. C. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103866 · Cited by 67
Expanding the phenotype of GMPPB mutations
Cabrera‐Serrano, M., Ghaoui, R., Ravenscroft, G., Johnsen, R. D., Davis, M. R., Corbett, A., Reddel, S., Sue, C. M., Liang, C., Waddell, L. B., et al. (2015) · Brain · doi:10.1093/brain/awv013 · Cited by 67
Self-citationKanagawa, M., Omori, Y., Sato, S., Kobayashi, K., Miyagoe‐Suzuki, Y., Takeda, S., Endo, T., Furukawa, T., & Toda, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116343 · Cited by 66
Morphological and functional aspects of progenitors perturbed in cortical malformations
Bizzotto, S., & Francis, F. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00030 · Cited by 51
Kanagawa, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313162 · Cited by 63
Congenital Muscular Dystrophies: Toward Molecular Therapeutic Interventions
Collins, J. J., & Bönnemann, C. G. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0092-8 · Cited by 62
Mammalian O-mannosyl glycans: Biochemistry and glycopathology
Endo, T. (2019) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.95.004 · Cited by 61
Glycoproteomic characterization of recombinant mouse α-dystroglycan
Harrison, R., Hitchen, P. G., Panico, M., Morris, H. R., Mekhaiel, D., Pleass, R. J., Dell, A., Hewitt, J. E., & Haslam, S. M. (2012) · Glycobiology · doi:10.1093/glycob/cws002 · Cited by 58
Ataxia, Intellectual Disability, and Ocular Apraxia with Cerebellar Cysts: A New Disease?
Poretti, A., Häusler, M., von Moers, A., Baumgartner, B., Zerres, K., Klein, A., Aiello, C., Moro, F., Zanni, G., Santorelli, F. M., et al. (2013) · The Cerebellum · doi:10.1007/s12311-013-0521-8 · Cited by 59
Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients
Weller, S., Rosewich, H., & Gärtner, J. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0856-3 · Cited by 58
“The brain malformations consist of cobblestone lissencephaly and possibly agyric findings in Walker–Warburg syndrome (Godfrey et al 2007; Martin 2006).”
BackgroundClinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent
Chakravorty, S., Nallamilli, B. R. R., Khadilkar, S. V., Singla, M. B., Bhutada, A. G., Dastur, R., Gaitonde, P., Rufibach, L., Gloster, L., & Hegde, M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.559327 · Cited by 58
Kanagawa, M., Yu, C.-C., Ito, C., Fukada, S., Hozoji-Inada, M., Chiyo, T., Kuga, A., Matsuo, M., Sato, K., Yamaguchi, M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt157 · Cited by 57
Clarke, N. F., Maugenre, S., Vandebrouck, A., Urtizberea, J. A., Willer, T., Peat, R. A., Gray, F., Bouchet, C., Manya, H., Vuillaumier‐Barrot, S., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.212 · Cited by 56
The inside and out of dystroglycan post-translational modification
Moore, C. J., & Winder, S. J. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.05.016 · Cited by 57
Johnson, K., Bértoli, M., Phillips, L. C., Töpf, A., den Bergh, P. Y. K. V., Vissing, J., Witting, N., Nafissi, S., Jamal-Omidi, S., Łusakowska, A., et al. (2018) · Skeletal Muscle · doi:10.1186/s13395-018-0170-1 · Cited by 56
Self-citationDiagnostic Approach to Cerebellar Hypoplasia
Accogli, A., Addour-Boudrahem, N., & Srour, M. (2021) · The Cerebellum · doi:10.1007/s12311-020-01224-5 · Cited by 53
Congenital muscular dystrophy. Part II: a review of pathogenesis and therapeutic perspectives
Reed, U. C. (2009) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2009000200035 · Cited by 53
Developmental disorders of the midbrain and hindbrain
Barkovich, A. J. (2012) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2012.00007 · Cited by 52
The Limb-Girdle Muscular Dystrophies and the Dystrophinopathies
Iyadurai, S. J. P., & Kissel, J. T. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000406 · Cited by 52
Mutations inPOMGNT1cause non-syndromic retinitis pigmentosa
Xu, M., Yamada, T., Sun, Z., Eblimit, A., López, I., Wang, F., Manya, H., Xu, S., Zhao, L., Li, Y., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw022 · Cited by 51
Metadata
- Authors
- Godfrey, C., Clement, E., Mein, R., Brockington, M., Smith, J., Talim, B., Straub, V., Robb, S., Quinlivan, R., Feng, L., Jimenez-Mallebrera, C., Mercuri, E., Manzur, A. Y., Kinali, M., Torelli, S., Brown, S. C., Sewry, C. A., Bushby, K., Topaloglu, H., North, K., Abbs, S., & Muntoni, F.
- Affiliations
- The University of Sydney (AU)
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10-01
- Volume
- 130
- Issue
- 10
- Pages
- 2725-2735
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2128173275
- Cited by
- 441
- References
- 35
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 13 · 2023: 21 · 2022: 13 · 2021: 24 · 2020: 23 · 2019: 21 · 2018: 23 · 2017: 21 · 2016: 22 · 2015: 24 · 2014: 33 · 2013: 34 · 2012: 35
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- dystroglycanopathies, alpha-dystroglycan glycosylation, genotype-phenotype correlation, POMT1, POMT2, POMGnT1, fukutin, LARGE, limb-girdle muscular dystrophy, Walker-Warburg syndrome, compound heterozygosity
- MeSH terms
- Child, Preschool, DNA Mutational Analysis, Glycosylation, Humans, Infant, Male, Mannosyltransferases, Membrane Proteins, Muscular Dystrophies, Mutation, Phenotype, Cohort Studies, N-Acetylglucosaminyltransferases, Dystroglycans, Muscular Dystrophies, Limb-Girdle
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.